• Something wrong with this record ?

Evidence-based management of ACS

Published
St. Louis : Mosby, 2005
Series
American heart journal, ISSN 0002-8703 vol. 149, no.4, suppl., April 2005
Pagination
106 s. : il. ; 28 cm

Language English Country United States

Document type Collected Work

Persistent link   https://www.medvik.cz/link/MED00155359
Main publication

The American heart journal.

"This supplement is based on the proceedings of a symposium, Staying the Course: Evidence-based Management of ACS, held on March 9, 2004, at the time of the 2004 Scientific Session of the American College of Cardiology. The symposium was jointly sponsored by the Duke School of Medicine and The Exeter Group, and suppored by an educational grant from Aventis Pharmaceuticals."

Bibliography, etc.

Obsahuje bibliografii

Owner Details Services
NLK NLK 2005 Shelf no. B 233/149-4-S.-2005 [1]
Volume Location Shelf no. Status Order
000      
00000nam 2200000 a 4500
001      
MED00155359
003      
CZ-PrNML
005      
20141219163715.0
008      
070503s2005 xxu e eng||
009      
BK
020    __
$q (Brož.)
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu $c US
072    _7
$x Farmacie. Farmakologie $a 615 $2 Konspekt $7 sk136315
080    __
$a 616.13 $2 h
080    __
$a 612.17 $2 h
080    __
$a 616-005 $2 h
080    __
$a 616.12/.14 $2 h
080    __
$a 616-005 $2 h
080    __
$a 615 $2 h
111    2_
$a Evidence-based Management of ACS $d (2004 : $c New Orleans, Louisiana) $7 xx0064629
245    10
$a Evidence-based management of ACS
260    __
$a St. Louis : $b Mosby, $c 2005
300    __
$a 106 s. : $b il. ; $c 28 cm
490    1_
$a American heart journal, $x 0002-8703 ; $v vol. 149, no.4, suppl., April 2005
500    __
$a "This supplement is based on the proceedings of a symposium, Staying the Course: Evidence-based Management of ACS, held on March 9, 2004, at the time of the 2004 Scientific Session of the American College of Cardiology. The symposium was jointly sponsored by the Duke School of Medicine and The Exeter Group, and suppored by an educational grant from Aventis Pharmaceuticals."
504    __
$a Obsahuje bibliografii
650    07
$a kardiologie $2 mednas $7 nlk20040147870
650    07
$a angiologie $2 mednas $7 nlk20040148017
650    07
$a farmacie a farmakologie $2 mednas $7 nlk20040147252
650    07
$a infarkt myokardu $x farmakoterapie $2 czmesh $7 D009203
650    07
$a akutní nemoc $x terapie $2 czmesh $7 D000208
650    07
$a enoxaparin $x terapeutické užití $2 czmesh $7 D017984
650    07
$a koronární trombóza $x farmakoterapie $2 czmesh $7 D003328
650    07
$a trombolytická terapie $2 czmesh $7 D015912
650    07
$a trombocytový glykoproteinový komplex IIb-IIIa $x antagonisté a inhibitory $2 czmesh $7 D019039
650    07
$a medicína založená na důkazech $2 czmesh $7 D019317
650    07
$a management nemoci $2 czmesh $7 D019468
655    _7
$a sborníky $2 czmesh $7 D020470
830    _4
$a The American heart journal
910    __
$a ABA008 $b B 233/149-4-S.-2005 $y x
990    __
$a 20070503095918 $b ABA008
991    __
$a 20070627101802 $b ABA008
999    __
$a ok $b medvik21 $g 136691 $s 155448
BAS    __
$a 02 $a 12 $a 30
LKV    __
$a MED00000228 $b 2005 149 4 suppl. $d 32395
LZP    __
$b 23/16.4.2007